Johns Hopkins Center for Infectious Diseases in India

10/15/2025

We’re excited to congratulate Claire Vania (WSE ’23) and Dr. Anushruti Gupta (BSPH ’22), both Johns Hopkins alumni, on receiving the 2025 Vivli AMR Visionary Award Grand Prize.

Dr. Gupta and Vania created an innovative dashboard that uses machine learning and causal modeling to predict antimicrobial resistance trends, allowing for policymakers to create effective, data-informed policies with less trial and error.

Read more about their project: https://www.hopkinscidi.org/vivli-amr-award-2025

10/09/2025

Co-Director of the Center for Infectious Diseases Sunil Suhas Solomon was recently featured in a Johns Hopkins Medicine article on the impact of funding cuts to HIV services. There is an estimated 2.4 million people with HIV, and India has the second highest burden of HIV globally.

Funded under a PEPFAR grant administered by USAID, he employed a team of nearly 700 people in both the U.S and India to develop, implement, and evaluate community outreach, testing, treatment, education, and care retention services to mitigate the epidemic among children, adolescents, and adults.

Through Project ACCELERATE, Dr. Solomon and his team reached more than 170,000 people across six Indian states, providing tailored care for transgender individuals and adolescents. "“Kids need to take ART to survive, but to really live and thrive, they need to have fun. We were in the process of evaluating the impact of these initiatives—when we first started the activities, viral suppression among teens at one of our centers was 67%. At our last evaluation, it was 95%,” he said.

On January 24, 2025, Dr. Solomon received a stop work order from USAID and in February 2025, the award was fully terminated, including the live-saving care that Solomon’s team was providing.

Review the article and learn about other impacts it's having in India and here at Hopkins: https://www.hopkinsmedicine.org/news/articles/2025/09/hiv-services-for-key-populations-affected-by-funding-cuts

10/07/2025

On September 16, 2025, scientists, researchers, and advocates from around the world gathered for 24 Hours to Save AIDS Research, a global event highlighting decades of progress made possible through federal investment in AIDS research and the urgent need to protect these gains.

In Hour 7, CIDI's co-director Sunil Suhas Solomon, Vice Chair for Research, Johns Hopkins School of Medicine​, delivered a talk on: “Heroin to Health: Global drugs, global diseases, global solutions.”

Watch Dr. Solomon’s full presentation and learn more about the need to protect HIV/AIDS research: https://youtu.be/_t0RelV4KW0?si=l0i4GyzBpu248fmu&t=1510

04/11/2025

Congratulations to our very own co-director Sunil Solomon, who has been named Vice Chair for Research in Johns Hopkins University School of Medicine's Department of Medicine.

"Dr. Solomon’s immense experience as an investigator will serve him well as he aims to support DOM faculty and aid them in the diversification of their funding to continue to move our research forward."

Johns Hopkins Bloomberg School of Public Health Gupta-Klinsky India Institute

https://medicine-matters.blogs.hopkinsmedicine.org/2025/04/gelber-melia-and-solomon-named-vice-chairs/

11/25/2024

Check out the great work by Dr. Matthew Robinson, Dr. Anushruti Gupta, Dr. Trish Simner, and some of our other partners!

In the spring and summer of 2024, The Johns Hopkins University scientists conducted two onsite trainings to build and expand laboratory capacity and standardize for as part of the Centers for Disease Control and Prevention's Global Action in Healthcare Network.

Together with three hospitals in Pune and Mumbai, India, they're using whole-genome sequencing to combat antimicrobial resistance (AR) threats.

Learn about CDC work with partners in India using whole genome sequencing to combat AR.

03/22/2024

TODAY at 2:30 ET: Be sure to join the virtual Comstock Lecture for with Dr. Neel R. Gandhi, MD, an Infectious Disease Epidemiologist and Physician, and Professor of Epidemiology at Emory University’s Rollins School of Public Health.

Established in 2008 to honor Dr. George W. Comstock’s lifetime of work in public health and tuberculosis control, this annual lecture given by distinguished leaders ...

02/08/2024

We can't wait for you to join us! And remember to register for the webinar link!

https://jhjhm.zoom.us/webinar/register/WN_BKxF5KX0TsaW1EtL6AVsfA #/registration

The Johns Hopkins Center for Infectious Diseases in India and the Gupta-Klinsky India Institute are excited to announce they are co-hosting a special guest lecture with Dr. George M Varghese, Head of Infectious Diseases at Christian Medical College Vellore, and the Head of the Clinical Infectious Diseases Society of India, Tuesday, Feb, 20, at 11 a.m. ET/ 9:30 p.m. IST. Register below!

His talk, "Innovation for Transformative Impact: Saving Lives in India,” will underscore the critical role of innovative solutions and approaches in addressing the intricate healthcare needs, particularly within the Indian context. Drawing from his research endeavors, Dr. Varghese will discuss how innovative strategies can effectively tackle pertinent healthcare challenges. He will also explain the advantages of leveraging innovation to catalyze significant and positive changes in healthcare outcomes by delving into specific research inquiries.



https://jhjhm.zoom.us/webinar/register/WN_BKxF5KX0TsaW1EtL6AVsfA #/registration

01/24/2024

01/16/2024

this week comes from Hyderabad! Through the support of The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and USAID, ACCELERATE treatment buddies continue to exemplify what it means to care for a person and not just the disease!

Telangana State AIDS Control Society - TSACS, Johns Hopkins Medicine, Y.R. Gaitonde Centre for AIDS Research and Education, Johns Hopkins Center for Infectious Diseases in India

12/01/2023

PEPFAR, or the President’s Emergency Plan for AIDS Relief, was initiated by President Bush in 2003 is credited with saving 25 million lives over the past 20 years and remains the largest commitment to a single disease in history. But the global bipartisan program is now at the mercy of American po...

11/17/2023

Saturday is the last day to check out CIDI faculty and Johns Hopkins India partners sessions at the on ! Check out the last ones below:
Session times noted in Central European Time

08:30-10:00 | Location: 243
SOA22 Drug sensitive TB: Treatment and Care: Short Oral Abstract Session
-Nishi Suryavanshi: Chair | Speaker: SOA22-971-18 The socio-economic impact of the COVID-19 pandemic in households having children with rifampicin-resistant TB: A qualitative study from South Africa, India and the Philippines
10:15-11:45 | Location: 202/203
SP49 Into the unknown: Drug-resistant TB in pregnancy: Symposium
Jyoti Mathad: Chair
-Mallika Alexander: Chair | Speaker: A case-based discussion of drug-resistant TB in pregnancy
13:15-14:45 | Location: 242A
OA68 Diagnosis for TB Diagnosis: Oral Abstract Session
-Sanjay Gaikwad: Speaker: OA68-739-18 Early microbiologic surrogate markers of pulmonary TB treatment outcomes
13:15 - 14:45 | Location: 241
OA69 TB stigma, discrimination and equity: Oral Abstract Session
-Abhay Kadam: Speaker: OA69-745-18 TB-related stigma among TB survivors and their household contacts: an overlooked but major barrier to TB elimination in India
-Dr. Gauri (Hemlata) Dhumal: Speaker: OA69-749-18 Creating-A-Hope: most preferred psycho-social intervention among adolescents and young adults with multidrug-resistant TB to improve programmatic outcomes in Pune, India
13:15 - 14:00 | Location: Foyer Bleu Paris
CC-24 A new approach to accelerate research and close gaps in access to new TB drugs for children: Community Connect Session
-Mandar Paradkar: Chair

11/15/2023

Thursday's sessions at the on featuring CIDI faculty and Johns Hopkins India partners are coming up soon! Be sure to attend them!
Session times noted in Central European Time

18:30-2:00 | Location: 242A
SS10 BENEFIT Kids: Better Evidence and Formulations to Improved Multidrug-Resistant Tuberculosis Treatment in Children: Satellite Session
Nishi Suryavanshi: Speaker: CATALYST: Acceptability of novel moxifloxacin and clofazimine formulations in children with MDR-TB: sociobehavioural data from South Africa, the Philippines and India

16:45-18:15 | Location: 242A
OA28 Into the unknown: gender, TB and pregnancy: Oral Abstract Session
Jyoti Mathad, Chair
Mallika Alexander, Speaker: OA28-421-16 High prevalence of antepartum and postpartum depressive symptoms and their association with active TB: Findings from a prospective longitudinal cohort of pregnant and postpartum Indian women